ID: ALA4784572

Max Phase: Preclinical

Molecular Formula: C26H16FNO6S

Molecular Weight: 489.48

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=C1c2ccccc2C(=O)c2c1cc(NS(=O)(=O)c1ccc(-c3ccc(F)cc3)cc1)c(O)c2O

Standard InChI:  InChI=1S/C26H16FNO6S/c27-16-9-5-14(6-10-16)15-7-11-17(12-8-15)35(33,34)28-21-13-20-22(26(32)25(21)31)24(30)19-4-2-1-3-18(19)23(20)29/h1-13,28,31-32H

Standard InChI Key:  XUFUSLRJLDHJCU-UHFFFAOYSA-N

Associated Targets(Human)

Phosphoglycerate mutase 1 143 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

NCI-H1299 3248 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A549 127892 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

PC-9 1037 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 489.48Molecular Weight (Monoisotopic): 489.0682AlogP: 4.48#Rotatable Bonds: 4
Polar Surface Area: 120.77Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 6.64CX Basic pKa: CX LogP: 5.89CX LogD: 4.59
Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.32Np Likeness Score: -0.40

References

1. Huang K,Jiang L,Liang R,Li H,Ruan X,Shan C,Ye D,Zhou L.  (2019)  Synthesis and biological evaluation of anthraquinone derivatives as allosteric phosphoglycerate mutase 1 inhibitors for cancer treatment.,  168  [PMID:30798052] [10.1016/j.ejmech.2019.01.085]

Source